Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and Exercise.

NCT01561404 is registered in ClinicalTrials.gov with Josep M Cruzado as lead sponsor.

NCT NCT01561404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01561404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and Exercise.
Lead sponsor
Josep M Cruzado
Phase
Phase 4
Overall status
Terminated
Start date
September 30, 2011
Completion date
December 31, 2013
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disorder related to renal transplantation, exercise, aerobic, muscle strength